1. Home
  2. NYXH vs OPP Comparison

NYXH vs OPP Comparison

Compare NYXH & OPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NYXH
  • OPP
  • Stock Information
  • Founded
  • NYXH 2009
  • OPP 2010
  • Country
  • NYXH Belgium
  • OPP United States
  • Employees
  • NYXH N/A
  • OPP N/A
  • Industry
  • NYXH Medical/Dental Instruments
  • OPP Finance/Investors Services
  • Sector
  • NYXH Health Care
  • OPP Finance
  • Exchange
  • NYXH Nasdaq
  • OPP Nasdaq
  • Market Cap
  • NYXH 188.1M
  • OPP 204.0M
  • IPO Year
  • NYXH 2021
  • OPP N/A
  • Fundamental
  • Price
  • NYXH $4.97
  • OPP $8.05
  • Analyst Decision
  • NYXH Strong Buy
  • OPP
  • Analyst Count
  • NYXH 3
  • OPP 0
  • Target Price
  • NYXH $15.00
  • OPP N/A
  • AVG Volume (30 Days)
  • NYXH 38.8K
  • OPP 108.0K
  • Earning Date
  • NYXH 11-13-2025
  • OPP 01-01-0001
  • Dividend Yield
  • NYXH N/A
  • OPP 14.41%
  • EPS Growth
  • NYXH N/A
  • OPP N/A
  • EPS
  • NYXH N/A
  • OPP N/A
  • Revenue
  • NYXH $5,793,306.00
  • OPP N/A
  • Revenue This Year
  • NYXH $85.62
  • OPP N/A
  • Revenue Next Year
  • NYXH $320.09
  • OPP N/A
  • P/E Ratio
  • NYXH N/A
  • OPP N/A
  • Revenue Growth
  • NYXH 2.94
  • OPP N/A
  • 52 Week Low
  • NYXH $4.35
  • OPP $7.26
  • 52 Week High
  • NYXH $11.87
  • OPP $8.83
  • Technical
  • Relative Strength Index (RSI)
  • NYXH 38.54
  • OPP 34.79
  • Support Level
  • NYXH $4.80
  • OPP $7.99
  • Resistance Level
  • NYXH $5.96
  • OPP $8.19
  • Average True Range (ATR)
  • NYXH 0.24
  • OPP 0.09
  • MACD
  • NYXH -0.06
  • OPP -0.00
  • Stochastic Oscillator
  • NYXH 14.66
  • OPP 14.63

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.

RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.

Share on Social Networks: